BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 11520525)

  • 1. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
    Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
    Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
    Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
    Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L; Borio L; Masur H; Kovacs JA
    J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
    Mei Q; Gurunathan S; Masur H; Kovacs JA
    Lancet; 1998 May; 351(9116):1631-2. PubMed ID: 9620722
    [No Abstract]   [Full Text] [Related]  

  • 5. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
    Alvarez-Martínez MJ; Miró JM; Valls ME; Mas J; de la Bellacasa JP; Sued O; Solé M; Rivas PV; de Lazzari E; Benito N; García F; Agustí C; Wilson PE; Gatell JM; Jiménez de Anta MT; Meshnick SR; Moreno A
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):60-5. PubMed ID: 20727472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
    Takahashi T; Hosoya N; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Nakamura Y; Iwamoto A
    J Clin Microbiol; 2000 Sep; 38(9):3161-4. PubMed ID: 10970350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
    Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
    AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Chaudhry R
    J Infect Dev Ctries; 2010 Nov; 4(11):761-6. PubMed ID: 21252456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China.
    Kazanjian PH; Fisk D; Armstrong W; Shulin Q; Liwei H; Ke Z; Meshnick S
    J Infect Dis; 2004 May; 189(9):1684-7. PubMed ID: 15116306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.
    Friaza V; Morilla R; Respaldiza N; de la Horra C; Calderón EJ
    Postgrad Med; 2010 Nov; 122(6):24-8. PubMed ID: 21084778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
    Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
    J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.
    Takahashi T; Kanda T; Iwamoto A
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):159-76. PubMed ID: 15080506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia.
    Visconti E; Ortona E; Mencarini P; Margutti P; Marinaci S; Zolfo M; Siracusano A; Tamburrini E
    Int J Antimicrob Agents; 2001 Dec; 18(6):547-51. PubMed ID: 11738342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of PCP episodes caused by Pneumocystis carinii with mutant dihydropteroate (DHPS) gene.
    Visconti E; Ortona E; Margutti P; Marinaci S; Zolfo M; Celentano LP; Mencarini P; Siracusano A; Tamburrini E
    J Eukaryot Microbiol; 1999; 46(5):135S. PubMed ID: 10519288
    [No Abstract]   [Full Text] [Related]  

  • 16. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
    Kazanjian P; Armstrong W; Hossler PA; Burman W; Richardson J; Lee CH; Crane L; Katz J; Meshnick SR
    J Infect Dis; 2000 Aug; 182(2):551-7. PubMed ID: 10915088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations.
    Crothers K; Beard CB; Turner J; Groner G; Fox M; Morris A; Eiser S; Huang L
    AIDS; 2005 May; 19(8):801-5. PubMed ID: 15867494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
    Huang L; Morris AM; Beard CB
    J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-resistant Pneumocystis carinii.
    Meshnick SR
    Lancet; 1999 Oct; 354(9187):1318-9. PubMed ID: 10533856
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia.
    Zar HJ; Alvarez-Martinez MJ; Harrison A; Meshnick SR
    Clin Infect Dis; 2004 Oct; 39(7):1047-51. PubMed ID: 15472859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.